Jefferies Financial Group Raises Pediatrix Medical Group (NYSE:MD) Price Target to $18.00

Pediatrix Medical Group (NYSE:MD) had its price target hoisted by analysts at Jefferies Financial Group from $14.00 to $18.00 in a report issued on Tuesday, Benzinga reports. The firm currently has a “buy” rating on the stock. Jefferies Financial Group’s price target would indicate a potential upside of 18.89% from the company’s previous close.

Several other equities research analysts have also recently weighed in on the company. UBS Group upped their target price on Pediatrix Medical Group from $9.00 to $10.50 and gave the stock a “neutral” rating in a report on Friday, August 9th. StockNews.com raised shares of Pediatrix Medical Group from a “sell” rating to a “hold” rating in a research note on Wednesday, August 7th. Deutsche Bank Aktiengesellschaft raised their target price on shares of Pediatrix Medical Group from $9.00 to $15.00 and gave the company a “hold” rating in a research report on Monday. Truist Financial increased their price objective on shares of Pediatrix Medical Group from $13.00 to $16.00 and gave the company a “hold” rating in a research note on Monday. Finally, Mizuho boosted their price objective on shares of Pediatrix Medical Group from $13.00 to $15.00 and gave the stock a “neutral” rating in a research note on Monday. Five analysts have rated the stock with a hold rating and one has issued a buy rating to the company. Based on data from MarketBeat, the company currently has a consensus rating of “Hold” and a consensus price target of $14.90.

Pediatrix Medical Group Trading Down 0.5 %

Shares of MD opened at $15.14 on Tuesday. The firm has a market capitalization of $1.30 billion, a price-to-earnings ratio of -4.95, a PEG ratio of 2.36 and a beta of 1.55. The company has a debt-to-equity ratio of 0.86, a current ratio of 1.58 and a quick ratio of 1.38. Pediatrix Medical Group has a 1-year low of $6.62 and a 1-year high of $15.43. The company has a 50-day moving average of $11.70 and a 200 day moving average of $9.45.

Pediatrix Medical Group (NYSE:MD) last posted its quarterly earnings results on Friday, November 1st. The company reported $0.44 earnings per share for the quarter, beating the consensus estimate of $0.37 by $0.07. The firm had revenue of $511.20 million during the quarter, compared to the consensus estimate of $498.87 million. Pediatrix Medical Group had a negative net margin of 12.65% and a positive return on equity of 12.79%. The company’s revenue was up .9% on a year-over-year basis. During the same quarter in the previous year, the firm posted $0.29 earnings per share. On average, research analysts expect that Pediatrix Medical Group will post 1.19 EPS for the current year.

Insider Buying and Selling at Pediatrix Medical Group

In other news, CFO C Marc Richards sold 32,562 shares of the firm’s stock in a transaction on Friday, August 9th. The stock was sold at an average price of $10.08, for a total value of $328,224.96. Following the completion of the sale, the chief financial officer now owns 192,785 shares of the company’s stock, valued at $1,943,272.80. This trade represents a 0.00 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. In other Pediatrix Medical Group news, CEO James D. Swift sold 11,100 shares of the company’s stock in a transaction that occurred on Friday, August 30th. The shares were sold at an average price of $10.79, for a total transaction of $119,769.00. Following the transaction, the chief executive officer now owns 170,001 shares in the company, valued at approximately $1,834,310.79. This represents a 0.00 % decrease in their position. The sale was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, CFO C Marc Richards sold 32,562 shares of Pediatrix Medical Group stock in a transaction on Friday, August 9th. The stock was sold at an average price of $10.08, for a total transaction of $328,224.96. Following the sale, the chief financial officer now owns 192,785 shares of the company’s stock, valued at $1,943,272.80. The trade was a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 68,100 shares of company stock worth $701,889 over the last three months. Corporate insiders own 1.20% of the company’s stock.

Hedge Funds Weigh In On Pediatrix Medical Group

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in the company. The Manufacturers Life Insurance Company increased its holdings in shares of Pediatrix Medical Group by 3.5% in the second quarter. The Manufacturers Life Insurance Company now owns 32,387 shares of the company’s stock valued at $245,000 after purchasing an additional 1,088 shares during the period. ProShare Advisors LLC increased its stake in shares of Pediatrix Medical Group by 7.4% in the first quarter. ProShare Advisors LLC now owns 16,937 shares of the company’s stock worth $170,000 after acquiring an additional 1,167 shares during the period. Nisa Investment Advisors LLC raised its holdings in shares of Pediatrix Medical Group by 47.2% during the second quarter. Nisa Investment Advisors LLC now owns 4,755 shares of the company’s stock worth $36,000 after purchasing an additional 1,524 shares during the last quarter. SummerHaven Investment Management LLC lifted its position in Pediatrix Medical Group by 3.8% during the second quarter. SummerHaven Investment Management LLC now owns 55,951 shares of the company’s stock valued at $422,000 after purchasing an additional 2,069 shares during the period. Finally, Bank of Montreal Can boosted its holdings in Pediatrix Medical Group by 0.5% in the second quarter. Bank of Montreal Can now owns 415,110 shares of the company’s stock valued at $3,196,000 after purchasing an additional 2,083 shares during the last quarter. Hedge funds and other institutional investors own 97.71% of the company’s stock.

Pediatrix Medical Group Company Profile

Pediatrix Medical Group, Inc, together with its subsidiaries, provides newborn, maternal-fetal, pediatric cardiology, and other pediatric subspecialty care services in the United States. It offers neonatal care services, such as clinical care to babies born prematurely or with complications within specific units at hospitals through neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians.